LIMES SCHLOSSKLINIKEN AG (LIK.DE) Stock Fundamental Analysis
FRA:LIK - Deutsche Boerse Ag - DE000A0JDBC7 - Common Stock - Currency: EUR
Overall LIK gets a fundamental rating of 6 out of 10. We evaluated LIK against 27 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making LIK a very profitable company, without any liquidiy or solvency issues. LIK is growing strongly while it is still valued neutral. This is a good combination! These ratings would make LIK suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year LIK was profitable.
In multiple years LIK reported negative net income over the last 5 years.
In multiple years LIK reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of LIK (12.97%) is better than 100.00% of its industry peers.
LIK has a Return On Equity of 25.18%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
LIK has a Return On Invested Capital of 16.32%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LIK is significantly above the industry average of 5.67%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.97% | ||
| ROE | 25.18% | ||
| ROIC | 16.32% |
ROA(3y)15.82%
ROA(5y)6.58%
ROE(3y)41.01%
ROE(5y)14.54%
ROIC(3y)20.25%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 9.95%, LIK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Operating Margin of LIK (12.65%) is better than 92.59% of its industry peers.
LIK has a Gross Margin of 95.44%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
LIK's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.65% | ||
| PM (TTM) | 9.95% | ||
| GM | 95.44% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y0.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LIK is creating value.
Compared to 1 year ago, LIK has less shares outstanding
The number of shares outstanding for LIK has been increased compared to 5 years ago.
LIK has a better debt/assets ratio than last year.
2.2 Solvency
LIK has an Altman-Z score of 5.99. This indicates that LIK is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.99, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
LIK has a Debt/Equity ratio of 0.51. This is a neutral value indicating LIK is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.51, LIK belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.99 |
ROIC/WACC2.38
WACC6.87%
2.3 Liquidity
LIK has a Current Ratio of 3.45. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
LIK's Current ratio of 3.45 is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
LIK has a Quick Ratio of 3.43. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
LIK's Quick ratio of 3.43 is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
LIK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.36%, which is quite impressive.
The Revenue has grown by 39.82% in the past year. This is a very strong growth!
Measured over the past years, LIK shows a very strong growth in Revenue. The Revenue has been growing by 38.61% on average per year.
EPS 1Y (TTM)33.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.75%
Revenue 1Y (TTM)39.82%
Revenue growth 3Y50.34%
Revenue growth 5Y38.61%
Sales Q2Q%35.88%
3.2 Future
The Earnings Per Share is expected to grow by 41.41% on average over the next years. This is a very strong growth
Based on estimates for the next years, LIK will show a very strong growth in Revenue. The Revenue will grow by 20.84% on average per year.
EPS Next Y51.17%
EPS Next 2Y53.16%
EPS Next 3Y41.41%
EPS Next 5YN/A
Revenue Next Year15.52%
Revenue Next 2Y22.23%
Revenue Next 3Y20.84%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 22.37, the valuation of LIK can be described as rather expensive.
LIK's Price/Earnings is on the same level as the industry average.
LIK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.25.
LIK is valuated correctly with a Price/Forward Earnings ratio of 12.00.
LIK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LIK is cheaper than 70.37% of the companies in the same industry.
LIK's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.15.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.37 | ||
| Fwd PE | 12 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LIK is valued a bit more expensive than the industry average as 70.37% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.9 |
4.3 Compensation for Growth
LIK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LIK has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LIK's earnings are expected to grow with 41.41% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y53.16%
EPS Next 3Y41.41%
5. Dividend
5.1 Amount
LIK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:LIK (5/30/2025, 7:00:00 PM)
330
+16 (+5.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap95.70M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.37 | ||
| Fwd PE | 12 | ||
| P/S | 2.23 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.98 | ||
| P/tB | 14.88 | ||
| EV/EBITDA | 12.9 |
EPS(TTM)14.75
EY4.47%
EPS(NY)27.49
Fwd EY8.33%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS148.28
BVpS55.17
TBVpS22.17
PEG (NY)0.44
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.97% | ||
| ROE | 25.18% | ||
| ROCE | 18.99% | ||
| ROIC | 16.32% | ||
| ROICexc | 16.32% | ||
| ROICexgc | 24.51% | ||
| OM | 12.65% | ||
| PM (TTM) | 9.95% | ||
| GM | 95.44% | ||
| FCFM | N/A |
ROA(3y)15.82%
ROA(5y)6.58%
ROE(3y)41.01%
ROE(5y)14.54%
ROIC(3y)20.25%
ROIC(5y)N/A
ROICexc(3y)28.07%
ROICexc(5y)N/A
ROICexgc(3y)81.25%
ROICexgc(5y)N/A
ROCE(3y)23.56%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y0.44%
F-ScoreN/A
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.07 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z | 5.99 |
F-ScoreN/A
WACC6.87%
ROIC/WACC2.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.75%
EPS Next Y51.17%
EPS Next 2Y53.16%
EPS Next 3Y41.41%
EPS Next 5YN/A
Revenue 1Y (TTM)39.82%
Revenue growth 3Y50.34%
Revenue growth 5Y38.61%
Sales Q2Q%35.88%
Revenue Next Year15.52%
Revenue Next 2Y22.23%
Revenue Next 3Y20.84%
Revenue Next 5YN/A
EBIT growth 1Y12.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.82%
EBIT Next 3Y49.06%
EBIT Next 5Y35.28%
FCF growth 1Y-104.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.8%
OCF growth 3YN/A
OCF growth 5YN/A